By 
The Sei Foundation, a recognized non-profit organization, is reportedly evaluating a possible procurement of 23andMe, the leading genomics and biotechnology company. The main goal of this potential acquisition is to transition storage of genetic data to Blockchain technology. This represents a unique convergence of innovative technology with healthcare and genetic research — offering enhanced security and privacy of sensitive genetic information.
The implication of Blockchain technology in the world of genetic data holds immense potential. Additionally, harnessing Blockchain for this purpose promises enhanced privacy and security, while preventing abuses of such sensitive data. This move by Sei Foundation indicates a growing trend of Blockchain’s application in diverse fields, and particularly its usefulness in securing healthcare data.
23andMe, a top-tier genetic testing company, provides critical genetic data obtained from individuals worldwide, making it a rich resource for genetic studies. The potential transfer of this data to Blockchain could revolutionize the way genetic data is stored. It holds the guarantee of providing robust data security, preventing data breaches, and ensuring individuals’ privacy. This move underscores the growing interest in the integration of Blockchain with the increasingly burgeoning genetic testing marketplace.
This novel approach by the Sei Foundation further shows their commitment to harnessing the latest technology for social good. By considering the purchase of a leading player like 23andMe, Sei Foundation aims at pioneering a more secure and responsible way of handling genetic data. This venture may effectively smoothen the path ahead for integration of advanced technologies like Blockchain with healthcare and genetic studies, thereby making data storage more reliable and user privacy, more assured.
Source: CoinDesk
Comments